Annual Working Capital
$117.18 M
+$16.76 M+16.69%
December 31, 2023
Summary
- As of February 8, 2025, ALGS annual working capital is $117.18 million, with the most recent change of +$16.76 million (+16.69%) on December 31, 2023.
- During the last 3 years, ALGS annual working capital has fallen by -$102.56 million (-46.67%).
- ALGS annual working capital is now -46.67% below its all-time high of $219.74 million, reached on December 31, 2020.
Performance
ALGS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$58.87 M
-$17.14 M-22.55%
September 30, 2024
Summary
- As of February 8, 2025, ALGS quarterly working capital is $58.87 million, with the most recent change of -$17.14 million (-22.55%) on September 30, 2024.
- Over the past year, ALGS quarterly working capital has dropped by -$58.31 million (-49.76%).
- ALGS quarterly working capital is now -73.21% below its all-time high of $219.74 million, reached on December 31, 2020.
Performance
ALGS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ALGS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.7% | -49.8% |
| 3 y3 years | -46.7% | -27.6% |
| 5 y5 years | +38.0% | -27.6% |
ALGS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.2% | +16.7% | -64.4% | +12.8% |
| 5 y | 5-year | -46.7% | +16.7% | -73.2% | +12.8% |
| alltime | all time | -46.7% | +38.0% | -73.2% | +12.8% |
Aligos Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $58.87 M(-22.6%) |
| Jun 2024 | - | $76.01 M(-23.4%) |
| Mar 2024 | - | $99.18 M(-15.4%) |
| Dec 2023 | $117.18 M(+16.7%) | $117.18 M(+124.6%) |
| Sep 2023 | - | $52.17 M(-22.1%) |
| Jun 2023 | - | $67.02 M(-17.6%) |
| Mar 2023 | - | $81.35 M(-19.0%) |
| Dec 2022 | $100.42 M | $100.42 M(-16.0%) |
| Sep 2022 | - | $119.55 M(-12.1%) |
| Jun 2022 | - | $136.03 M(-11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $153.72 M(-7.1%) |
| Dec 2021 | $165.47 M(-24.7%) | $165.47 M(-22.6%) |
| Sep 2021 | - | $213.89 M(+28.4%) |
| Jun 2021 | - | $166.54 M(-14.4%) |
| Mar 2021 | - | $194.59 M(-11.4%) |
| Dec 2020 | $219.74 M(+106.5%) | $219.74 M(+309.1%) |
| Sep 2020 | - | $53.71 M(-54.0%) |
| Jun 2020 | - | $116.86 M(+9.8%) |
| Dec 2019 | $106.41 M(+25.4%) | $106.41 M |
| Dec 2018 | $84.88 M | - |
FAQ
- What is Aligos Therapeutics annual working capital?
- What is the all time high annual working capital for Aligos Therapeutics?
- What is Aligos Therapeutics annual working capital year-on-year change?
- What is Aligos Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly working capital year-on-year change?
What is Aligos Therapeutics annual working capital?
The current annual working capital of ALGS is $117.18 M
What is the all time high annual working capital for Aligos Therapeutics?
Aligos Therapeutics all-time high annual working capital is $219.74 M
What is Aligos Therapeutics annual working capital year-on-year change?
Over the past year, ALGS annual working capital has changed by +$16.76 M (+16.69%)
What is Aligos Therapeutics quarterly working capital?
The current quarterly working capital of ALGS is $58.87 M
What is the all time high quarterly working capital for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly working capital is $219.74 M
What is Aligos Therapeutics quarterly working capital year-on-year change?
Over the past year, ALGS quarterly working capital has changed by -$58.31 M (-49.76%)